BDF
CORT icon

Black Diamond Financial’s Corcept Therapeutics CORT Stock Holding History

Black Diamond Financial’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Buy
24,198
+16,998
+236% +$1.03M 0.19% 58
2026
Q1 		$290K Buy
7,200
+1,000
+16% +$37.4K 0.03% 147
2025
Q4 		$216K Sell
6,200
-1,500
-19% -$118K 0.02% 169
2025
Q3 		$640K Hold
7,700
– – 0.07% 86
2025
Q2 		$565K Buy
7,700
+2,500
+48% +$181K 0.09% 82
2025
Q1 		$594K Hold
5,200
– – 0.09% 84
2024
Q4 		$262K Buy
5,200
+200
+4% +$10.5K 0.04% 121
2024
Q3 		$231K Buy
+5,000
New +$178K 0.04% 124

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Black Diamond Financial's CORT Position: Q2 2026 in Review

Black Diamond Financial increased its Corcept Therapeutics (CORT) stake by 236% in Q2 2026, buying an estimated $1.03M and bringing the position to 24,198 shares worth $2.1M. The position accounts for 0.19% of the portfolio, ranked #58.

Black Diamond Financial first reported a position in CORT in Q3 2024 and has held it in 8 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Black Diamond Financial held 24,198 shares of Corcept Therapeutics worth $2.1M as of Q2 2026.
  • Black Diamond Financial bought 16,998 Corcept Therapeutics shares in Q2 2026, an estimated $1.03M.
  • Corcept Therapeutics made up 0.19% of Black Diamond Financial's portfolio in Q2 2026, its #58 holding.
  • Black Diamond Financial first reported a position in Corcept Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Black Diamond Financial's 13F filing for Q2 2026, filed 4 Aug 2026.